Closure of Trading Window for the quarter and year ending on March 31, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Genomic Valley Biotech Ltd has informed BSE that the trading window for its shares will remain closed from April 1, 2026, until 48 hours after the announcement of audited financial results for the quarter and year ended March 31, 2026. The closure is in line with SEBI's Insider Trading Regulations, 2015, and applies to employees, directors, key managerial personnel, designated persons, and their immediate relatives, who cannot trade in the company's shares during this period. The date of the board meeting to declare the audited results has not yet been disclosed and will be communicated later. The announcement was signed by Managing Director Yogesh Agrawal.
This is a routine regulatory filing required before the announcement of audited financial results and does not signal any material event. Investors should expect upcoming quarterly and annual results, which may move the stock once released, but the window closure itself has no direct impact on shareholders or stock price.